Sunshine Biopharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sunshine Biopharma Stock Summary

Sunshine Biopharma competes with Shionogi, China SXT, Shuttle Pharmaceuticals, Lifecore Biomedical, and Journey Medical. Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada. Sunshine Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Sunshine Biopharma Key Financial Ratios

Sunshine Biopharma Key Balance Sheet Accounts

Sunshine Biopharma Key Income Statement Accounts

Sunshine Biopharma Key Cash Accounts

Sunshine Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sunshine Biopharma's current stock value. Our valuation model uses many indicators to compare Sunshine Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sunshine Biopharma competition to find correlations between indicators driving Sunshine Biopharma's intrinsic value. More Info.Sunshine Biopharma is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Sunshine Biopharma's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sunshine Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Sunshine Biopharma Systematic Risk

Today, most investors in Sunshine Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sunshine Biopharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sunshine Biopharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sunshine Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sunshine Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sunshine Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Sunshine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sunshine Biopharma's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.